Chaincode Labs, founded in 2014 by HRT co-founders Alex Morcos and Suhas Daftuar, is dedicated to advancing Bitcoin development and aiding independent innovators within the Bitcoin ecosystem. Located in Midtown Manhattan, the organization provides resources and support to developers building on the Bitcoin network. Notably, several former HRT interns, including Meta's Chief AI Officer Alexandr Wang, have connections to Chaincode Labs, highlighting its influence in the blockchain community.
The story about Chaincode Labs, founded by HRT co-founders for Bitcoin development, is provided here with Pluang's cryptocurrency market data for context. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 19, 2026 15:02 WIB: out of 50 major cryptocurrencies priced on Pluang, 41 rose and 8 fell today. LINK (Chainlink) was priced at Rp220.262 with a 1-day change of +2.33%, Pluang order activity showed 64% Sell and 36% Buy, and the typical hold time was 63 days. ENJ (Enjin Coin) was at Rp491 with a 1-day change of -2.15%, with 95% Sell and 5% Buy activity, and a hold time of 105 days. FTM (Fantom) was priced at Rp11.382 with a 1-day change of -2.05% and a typical hold time of 88 days.
The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personali...
Starlink Mobile, launched by VEON Ltd. across Ukraine, Kazakhstan, and Bangladesh, has connected over 11 million users in less than a year. The service enables existing 4G phones to access satellite connectivity where terrestrial signals are unavaila...
Medallion Financial Corp. announced it will repurchase $15 million in trust preferred securities from BIMIZCI Fund LLC at 73.66% of face value, costing about $11.05 million plus accrued distributions. This deal includes a five-year standstill agreeme...
Belite Bio, a clinical-stage drug developer focused on retinal diseases, has been approved to move its stock listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest tier on Nasdaq. This uplisting reflects the company's ...
Heineken N.V. has repurchased a total of 8,865,521 shares under the second tranche of its €1.5 billion share buyback program, spending €629.4 million as of October 16, 2026. This includes shares bought on the exchange and from Heineken Holding N.V. T...
